SC II Acquisition
SCIIR · NASDAQ
About SCIIR
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Nov 26, 2025
- Sector
- N/A
- Industry
- N/A
SCIIR key statistics
- Market cap
- 255.45M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 30
- Volume
- 2.90K
- Open price
- $0.1023
- High today
- $0.15
- Low today
- $0.102
- 52 Week high
- $0.3001
- 52 Week low
- $0.1501
SC II Acquisition (SCIIR) at a glance
As of Nov 20, 2026, SC II Acquisition (SCIIR) shares are priced at $0.15, giving the company a market cap of 255.45M and a price-to-earnings ratio of 0.00.
On Nov 20, 2026, the stock traded between $0.102 and $0.15. Its last price was 47.1% above the day's low and 0.0% below its high.
Volume on Nov 20, 2026 reached 2.90K shares, above the average of 30 shares a day.
Over the past year SC II Acquisition has ranged from $0.1501 to $0.3001, and now sits 0% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- HIRUHiru$0.0004+0.00%
- NVDANVIDIA$125.84−13.80%
- SOXLDirexion Shares ETF Trust$30.88−31.84%
- ANTAnthropic PBC$88.30−9.13%
- NXATNexus Advanced Technologies$0.548+144.97%
- SPDNDirexion Shares ETF Trust$9.41+3.63%
- NIVFNewGenIvf Group$0.0269−23.14%
- TQQQProShares Trust$41.01−16.32%
- SNXXTradr 2X Long SNDK Daily ETF$1.76−31.52%
- AEFIAmerican EcoFuels$0.0005−16.67%
- INTCIntel$51.37−7.82%
Newly listed
Companies that went public in the past six weeks
- ANTAnthropic, PBC$88.30−9.13%
- WWBWINDWARD BIO GROUP AG$24.29+1.15%
- VVVVvVARDIS Holding AG$14.55−3.00%
- MDRNModern Mining Technology$2.85+21.28%
- NARANarragansett Bancorp$10.07−0.69%
- ASPEAspen Neuroscience$12.56+1.37%
- BBTXBambusa Therapeutics$16.00+2.89%
- GBCGEORGIA BANKING$34.25+0.91%
- BHAIUBHAV Acquisition Corp II$10.04+0.20%
- SCQCUSPACCircle Acquisition$10.02+0.10%
- LYCALycia Therapeutics$33.07+4.09%
- DAVIDAVION HEALTHCARE$0.9001−9.99%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.